PAHC
Price
$23.93
Change
-$0.58 (-2.37%)
Updated
Jun 13 closing price
Capitalization
523.71M
74 days until earnings call
ZTS
Price
$164.33
Change
-$4.49 (-2.66%)
Updated
Jun 13 closing price
Capitalization
77.48B
59 days until earnings call
Interact to see
Advertisement

PAHC vs ZTS

Header iconPAHC vs ZTS Comparison
Open Charts PAHC vs ZTSBanner chart's image
Phibro Animal Health
Price$23.93
Change-$0.58 (-2.37%)
Volume$152.03K
Capitalization523.71M
ZOETIS
Price$164.33
Change-$4.49 (-2.66%)
Volume$2.97M
Capitalization77.48B
PAHC vs ZTS Comparison Chart
Loading...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PAHC vs. ZTS commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAHC is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (PAHC: $23.93 vs. ZTS: $164.33)
Brand notoriety: PAHC: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PAHC: 64% vs. ZTS: 99%
Market capitalization -- PAHC: $523.71M vs. ZTS: $77.48B
PAHC [@Pharmaceuticals: Other] is valued at $523.71M. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAHC’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • PAHC’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAHC’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • PAHC’s TA Score: 4 bullish, 6 bearish.
  • ZTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than PAHC.

Price Growth

PAHC (@Pharmaceuticals: Other) experienced а -0.62% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -3.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

PAHC is expected to report earnings on Aug 27, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than PAHC($524M). PAHC (34.11) and ZTS (32.94) have similar P/E ratio . PAHC YTD gains are higher at: 15.091 vs. ZTS (1.506). ZTS has higher annual earnings (EBITDA): 3.67B vs. PAHC (83.7M). ZTS has more cash in the bank: 2.04B vs. PAHC (92.5M). PAHC has less debt than ZTS: PAHC (513M) vs ZTS (6.76B). ZTS has higher revenues than PAHC: ZTS (8.54B) vs PAHC (982M).
PAHCZTSPAHC / ZTS
Capitalization524M77.5B1%
EBITDA83.7M3.67B2%
Gain YTD15.0911.5061,002%
P/E Ratio34.1132.94104%
Revenue982M8.54B11%
Total Cash92.5M2.04B5%
Total Debt513M6.76B8%
FUNDAMENTALS RATINGS
PAHC vs ZTS: Fundamental Ratings
PAHC
ZTS
OUTLOOK RATING
1..100
2021
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
74
Overvalued
PROFIT vs RISK RATING
1..100
8372
SMR RATING
1..100
6219
PRICE GROWTH RATING
1..100
4553
P/E GROWTH RATING
1..100
9265
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (74) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (72) in the Pharmaceuticals Generic industry is in the same range as PAHC (83) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to PAHC’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for PAHC (62) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew somewhat faster than PAHC’s over the last 12 months.

PAHC's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as ZTS (53) in the Pharmaceuticals Generic industry. This means that PAHC’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's P/E Growth Rating (65) in the Pharmaceuticals Generic industry is in the same range as PAHC (92) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAHCZTS
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 19 days ago
57%
Declines
ODDS (%)
Bearish Trend 24 days ago
72%
Bearish Trend 25 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
61%
Bearish Trend 5 days ago
40%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAR36.013.02
+9.15%
Darling Ingredients
ZYXI2.100.03
+1.45%
Zynex
VRTS173.57-3.97
-2.24%
Virtus Investment Partners
AVGO248.70-7.37
-2.88%
Broadcom Inc.
REE0.63-0.06
-8.89%
REE Automotive Ltd

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-2.37%
PBH - PAHC
48%
Loosely correlated
-1.37%
ZTS - PAHC
40%
Loosely correlated
-2.66%
ASRT - PAHC
39%
Loosely correlated
+2.43%
VTRS - PAHC
37%
Loosely correlated
-1.87%
ELAN - PAHC
37%
Loosely correlated
-2.54%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.66%
VTRS - ZTS
42%
Loosely correlated
-1.87%
PAHC - ZTS
40%
Loosely correlated
-2.37%
AMRX - ZTS
38%
Loosely correlated
-2.64%
ELAN - ZTS
37%
Loosely correlated
-2.54%
AMPH - ZTS
34%
Loosely correlated
-2.34%
More